What is the recommended dosing regimen of nitrofurantoin (Macrobid) for an adult with an uncomplicated urinary tract infection and for prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Macrobid Dosing

For uncomplicated urinary tract infections in adults, prescribe nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days. 1

Treatment Dosing for Acute Uncomplicated Cystitis

Standard Regimen

  • Dose: 100 mg orally twice daily
  • Duration: 5 days for women 2
  • Administration: Take with food to enhance bioavailability by approximately 40% 1

The 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 86-92% 3. This duration is supported by high-quality evidence showing equivalence to trimethoprim-sulfamethoxazole 3-day therapy and superiority to single-dose fosfomycin 4.

Alternative Dosing Options

While the FDA label indicates 100 mg every 12 hours for 7 days 1, contemporary guidelines support the shorter 5-day course as equally effective with potentially better adherence 2. The macrocrystal formulation at 50-100 mg four times daily for 5 days is also acceptable 2.

Men with Uncomplicated Cystitis

  • Dose: 100 mg twice daily
  • Duration: 7 days 2

Men require longer treatment duration due to higher risk of prostatic involvement, though evidence specifically for nitrofurantoin in men is limited 5.

Prophylaxis Dosing for Recurrent UTI

For prevention of recurrent UTIs, prescribe 50 mg once daily at bedtime. 6

Prophylactic Regimen

  • Dose: 50 mg orally once daily (preferred) or 100 mg once daily
  • Timing: Bedtime administration or post-coital dosing
  • Duration: Continuous prophylaxis for 6-12 months

The 50 mg daily dose is strongly preferred over 100 mg for prophylaxis based on recent cohort data showing equivalent UTI prevention (hazard ratio 1.01,95% CI 0.78-1.30) but significantly fewer adverse effects 6. The 100 mg prophylactic dose was associated with increased risk of cough (HR 1.82), dyspnea (HR 2.68), and nausea (HR 2.43) compared to 50 mg 6.

Critical Renal Dosing Considerations

Avoid nitrofurantoin when creatinine clearance is <30 mL/min 5. This threshold represents strong consensus agreement, as urinary concentrations become insufficient for therapeutic efficacy below this level 5.

  • CrCl ≥30 mL/min: Standard dosing appropriate
  • **CrCl <30 mL/min:** Contraindicated - select alternative agent (ciprofloxacin, fosfomycin, or TMP-SMX if CrCl >15 mL/min) 5

The older recommendation to avoid nitrofurantoin at CrCl <60 mL/min lacks consensus support and is overly restrictive 5.

Key Clinical Pearls

Advantages Supporting First-Line Use

  • Narrow antimicrobial spectrum minimizes collateral damage to gut microbiome 7, 8
  • Extremely low resistance rates maintained over 50+ years of use 7, 8
  • High urinary concentrations with minimal systemic absorption 1, 8
  • Effective against ESBL-producing organisms and VRE 7

Common Pitfalls to Avoid

  1. Do not use for pyelonephritis or systemic infections - inadequate tissue penetration due to low serum levels 1, 8
  2. Do not prescribe without food - bioavailability increases 40% with meals 1
  3. Do not use in late pregnancy (≥38 weeks) - risk of hemolytic anemia in newborn 2
  4. Monitor for pulmonary reactions - rare but serious adverse effect, particularly with chronic use 5

Drug Interactions

Antagonism occurs with quinolone antibiotics in vitro; avoid concurrent use 1. Otherwise, nitrofurantoin has minimal clinically significant drug interactions compared to alternatives like TMP-SMX (warfarin, phenytoin interactions) 5.

When to Choose Alternatives

Select fosfomycin, TMP-SMX, or pivmecillinam instead when:

  • CrCl <30 mL/min
  • Suspected pyelonephritis or systemic infection
  • Known Proteus or Pseudomonas infection (intrinsically resistant) 1
  • Patient intolerance to nitrofurantoin

Related Questions

What are the recommended dosing regimens and frequencies for Macrobid (nitrofurantoin) in adults with uncomplicated urinary tract infection, for prophylaxis, and in pediatric patients?
What is the recommended nitrofurantoin 100 mg dosing schedule for an adult with an uncomplicated urinary tract infection?
What is the minimum duration of nitrofurantoin treatment for an uncomplicated urinary tract infection?
Can a patient on nitrofurantoin for a urinary tract infection be started on azithromycin for acute bronchitis, and what is the appropriate dosing regimen?
What is the recommended dose of nitrofurantoin for treating uncomplicated cystitis and for prophylaxis in adults, and what is the pediatric dosing regimen?
Is Avil 25 mg (meclizine) the best option for preventing motion‑sickness symptoms?
How should I manage a 60-year-old woman with 2 days of myalgia, flu-like symptoms, and multiple oral ulcers (one on the lower lip and two on the upper lip/roof of mouth) and a history of cold sores?
In a patient with a partially detached and degloved ear, how much time is available before surgical reattachment should be performed?
When should N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) be ordered and how are its levels interpreted for diagnosing and managing heart failure?
What is the appropriate management of hyponatremia?
Can I stop taking Eliwel (amitriptyline) 0.25 mg half tablet and Zapis (betahistine) whole tablet after a year of use for vertigo, and how should I taper them?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.